Developing an app to help young people self-manage when feeling overwhelmed during lessons

ISRCTN ISRCTN13425994
DOI https://doi.org/10.1186/ISRCTN13425994
Secondary identifying numbers 7969/001
Submission date
30/08/2016
Registration date
23/09/2016
Last edited
07/05/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
In England, between 3-7% of school aged children experience behavioural difficulties. Behavioural difficulties can have a negative long-term impact. For example, evidence shows that behavioural difficulties may predict worse academic attainment and higher levels of school dropout. Recent policy calls for schools to help students to manage behavioural difficulties. ReZone is a smartphone app for young people to use when they feel overwhelmed, stressed or anxious in class. The app aims to help students manage how they are feeling so they can ReZone and return to learning. It contains a series of tools which are designed to improve concentration, help relieve stress and help students to reflect and think through problems logically, through use of mentalisation based therapy (a type of therapy that helps people separate their thoughts and feelings from those around them) and cognitive behaviour therapy (a type of therapy aiming to help people to change negative behaviour patterns) techniques. The aim of this study is to test the effectiveness of ReZone at reducing emotional and behavioural difficulties in young people in need of targeted support to engage with school.

Who can participate?
Young people aged 10-15 years who attend alternative provision or mainstream primary schools.

What does the study involve?
Classes are randomly allocated to one of two groups. Students in the first group are given access to the ReZone app, which are downloaded on school tablets, for 12 weeks. They are able to use the app whenever they are feeling overwhelmed, stressed or anxious, either of their own accord or be directed by teachers to use it in class. The app contains tools based on cognitive behavioural therapy, mindfulness, and attention bias modification training to help students calm and re-focus quickly, enabling them to re-engage with their learning. Students in the second group continue as normal for the duration of the study. At the start of the study and then again after 12 weeks, students in both groups complete a range of questionnaires to measure their emotional and behavioural difficulties, mental wellbeing and self-management.

What are the possible benefits and risks of participating?
There is no guaranteed benefit in taking part. One advantage is that participants will get to help shape an app that will benefit young people in future. Most people find taking part in research rewarding, as they contribute to the development of knowledge that may benefit other people in the future. After the study has ended, all classes in schools taking part in the project will be able to use ReZone if they wish. There are no notable risks involved with participating in this study.

Where is the study run from?
The study is run by University College London and the Anna Freud National Centre for Children and Families and takes place in alternative provision or mainstream primary schools in England (UK)

When is the study starting and how long is it expected to run for?
August 2016 to June 2017

Who is funding the study?
National Institute for Health Research (UK)

Who is the main contact?
Dr Julian Edbrooke-Childs

Contact information

Dr Julian Edbrooke-Childs
Scientific

The Anna Freud Centre and University College London
12 Maresfield Gardens
London
NW3 5SU
United Kingdom

ORCiD logoORCID ID 0000-0003-0401-4058

Study information

Study designCluster randomised control study
Primary study designInterventional
Secondary study designCluster randomised trial
Study setting(s)School
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleCluster randomized control trial of ReZone: helping young people to self-manage when feeling overwhelmed
Study hypothesisPrimary aim:
To examine the effectiveness of an mHealth intervention (ReZone) in reducing emotional and behavioural difficulties in young people in need of targeted support to engage with school.

Secondary aim:
To examine the effectiveness of ReZone in improving self-management, well-being, and health-related quality of life in young people in need of targeted support to engage with school.
Ethics approval(s)UCL Ethics Committee, 27/09/2016, ref: 7969
ConditionEmotional and behavioural difficulties in young people
InterventionCurrent Interventions (as of 17/01/2018):
Classes are randomly allocated to the intervention or control arm using a random sequence generator by an independent trials unit.

Intervention arm: Students will be given access to the ReZone app for 12 weeks on school tablets. Students can use ReZone of their own accord or be directed by teachers to use it during classes at times the students is becoming overwhelmed. ReZone contains six tools based on attention bias modification training, art therapy, metallisation based therapy, and cognitive behaviour therapy techniques: the ‘stress bucket’ exercise, ‘time out’ incident clock, art zone, mindfulness breathing, happy faces and games.

Control arm: Students continue as normal for the duration of the study.

Participants in both groups complete measures of emotional and behavioural difficulties, mental wellbeing, self-management, and health-related quality of life at baseline and 12 weeks.

Previous interventions:
Classes are randomly allocated to the intervention or control arm using a random sequence generator by an independent trials unit.

Intervention arm: Students will be given access to the ReZone app for 12 weeks. They are able to download the ReZone app from the iTunes, Google play, and Windows app stores. Students can then use the app as much as they like, using the tools on the platform as well as being able to download flat graphics of tools. Students can use ReZone of their own accord or be directed by teachers to use it during classes at times the students is becoming overwhelmed. ReZone contains four tools based on art therapy, metallisation based therapy, and cognitive behaviour therapy techniques: the ‘stress bucket’ exercise, ‘time out’ incident clock, art zone, and mindfulness breathing.

Control arm: Students continue as normal for the duration of the study.

Participants in both groups complete measures of emotional and behavioural difficulties, mental wellbeing, self-management, and health-related quality of life at baseline and 12 weeks.
Intervention typeOther
Primary outcome measureEmotional and behavioural difficulties are measured using the 16-item Me and My School (M&MS) at baseline and 12 weeks completed by students.
Secondary outcome measures1. Mental wellbeing is measured using the 7-item Short Warwick-Edinburg Mental Well-being Scale (SWEMWBS) at baseline and 12 weeks completed by students
2. Self-management is measured using the 6-item “self” subscale of the Youth Empowerment Scale-Mental Health (YES-MH) at baseline and 12 weeks completed by students
3. Health-related quality of life is measured using the 6-item EQ-5D-Y at baseline and 12 weeks completed by students
Overall study start date01/08/2016
Overall study end date30/06/2017

Eligibility

Participant type(s)Other
Age groupChild
Lower age limit10 Years
Upper age limit15 Years
SexBoth
Target number of participants120
Participant inclusion criteriaCurrent participant inclusion criteria (as of 17/01/2018):
1. Young people aged 10-15 years
2. Attending alternative provision or mainstream primary schools
3. Able to understand English sufficiently to take part

Previous participant inclusion criteria:
1. Young people aged 11-14 years
2. Attending alternative provision schools
3. Able to understand English sufficiently to take part
Participant exclusion criteriaCurrent participant exclusion criteria (as of 17/01/2018):
1. Children (<10 years)
2. Adults (>15)
3. Not attending alternative provision or mainstream primary schools
4. Not able to understand English sufficiently to take part

Previous participant exclusion criteria:
1. Children (<11 years)
2. Adults (>15)
3. Not attending alternative provision schools
4. Not able to understand English sufficiently to take part
Recruitment start date01/02/2017
Recruitment end date01/06/2017

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centres

University College London
WC1E 6BT
United Kingdom
Anna Freud National Centre for Children and Families
NW3 5SU
United Kingdom

Sponsor information

University College London
University/education

Gower Street
London
WC1E 6BT
England
United Kingdom

ROR logo "ROR" https://ror.org/02jx3x895

Funders

Funder type

Government

National Institute for Health Research
Government organisation / National government
Alternative name(s)
National Institute for Health Research, NIHR Research, NIHRresearch, NIHR - National Institute for Health Research, NIHR (The National Institute for Health and Care Research), NIHR
Location
United Kingdom

Results and Publications

Intention to publish date30/11/2018
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planPlanned publication in a high-impact peer reviewed journal
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 03/11/2017 06/11/2017 Yes No
Results article results 02/05/2019 07/05/2019 Yes No

Editorial Notes

07/05/2019: Publication reference added.
17/01/2018: The following changes were made:
1. The overall trial start date was changed from 01/06/2016 to 01/08/2016.
2. Recruitment start date was changed from 01/11/2016 to 01/02/2017.
3. Recruitment end date was changed from 28/02/2017 to 01/06/2017.
4. The overall trial end date was changed from 30/11/2017 to 30/06/2017.
5. Interventions, participant inclusion criteria and participant exclusion criteria were udpated.
6. target number of participants was changed from 60 to 120.
06/11/2017: Publication reference added.
05/09/2017: Ethics approval information has been added.